Drug Shortage Report for LORAZEPAM INJECTION USP
| Report ID | 127901 |
| Drug Identification Number | 02388669 |
| Brand name | LORAZEPAM INJECTION USP |
| Common or Proper name | Lorazepam Injection USP |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | LORAZEPAM |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 x 1mL vial |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-12-18 |
| Estimated end date | |
| Actual end date | 2022-01-24 |
| Shortage status | Resolved |
| Updated date | 2022-01-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v16 | 2022-01-25 | English | Compare |
| v15 | 2022-01-24 | French | Compare |
| v14 | 2022-01-24 | English | Compare |
| v13 | 2021-08-03 | French | Compare |
| v12 | 2021-08-03 | English | Compare |
| v11 | 2021-07-06 | French | Compare |
| v10 | 2021-07-06 | English | Compare |
| v9 | 2021-05-12 | French | Compare |
| v8 | 2021-05-12 | English | Compare |
| v7 | 2021-03-02 | French | Compare |
| v6 | 2021-03-02 | English | Compare |
| v5 | 2020-12-21 | French | Compare |
| v4 | 2020-12-21 | English | Compare |
| v3 | 2020-12-16 | English | Compare |
| v2 | 2020-11-06 | French | Compare |
| v1 | 2020-11-06 | English | Compare |
Showing 1 to 16 of 16